S&P 500   3,635.41 (+1.62%)
DOW   30,046.24 (+1.54%)
QQQ   294.64 (+1.46%)
AAPL   115.15 (+1.14%)
MSFT   213.65 (+1.68%)
FB   276.92 (+3.16%)
GOOGL   1,763.90 (+2.10%)
AMZN   3,120.51 (+0.71%)
TSLA   555.74 (+6.49%)
NVDA   518.55 (-1.34%)
BABA   280.40 (+3.81%)
CGC   26.94 (+8.98%)
GE   10.45 (+3.77%)
MU   63.97 (-0.33%)
AMD   85.00 (-0.36%)
T   29.21 (+2.06%)
NIO   53.62 (-3.18%)
F   9.48 (+7.00%)
ACB   9.21 (+28.27%)
NFLX   482.90 (+1.32%)
GILD   60.25 (+0.60%)
BA   218.88 (+3.47%)
DIS   151.52 (+3.80%)
S&P 500   3,635.41 (+1.62%)
DOW   30,046.24 (+1.54%)
QQQ   294.64 (+1.46%)
AAPL   115.15 (+1.14%)
MSFT   213.65 (+1.68%)
FB   276.92 (+3.16%)
GOOGL   1,763.90 (+2.10%)
AMZN   3,120.51 (+0.71%)
TSLA   555.74 (+6.49%)
NVDA   518.55 (-1.34%)
BABA   280.40 (+3.81%)
CGC   26.94 (+8.98%)
GE   10.45 (+3.77%)
MU   63.97 (-0.33%)
AMD   85.00 (-0.36%)
T   29.21 (+2.06%)
NIO   53.62 (-3.18%)
F   9.48 (+7.00%)
ACB   9.21 (+28.27%)
NFLX   482.90 (+1.32%)
GILD   60.25 (+0.60%)
BA   218.88 (+3.47%)
DIS   151.52 (+3.80%)
S&P 500   3,635.41 (+1.62%)
DOW   30,046.24 (+1.54%)
QQQ   294.64 (+1.46%)
AAPL   115.15 (+1.14%)
MSFT   213.65 (+1.68%)
FB   276.92 (+3.16%)
GOOGL   1,763.90 (+2.10%)
AMZN   3,120.51 (+0.71%)
TSLA   555.74 (+6.49%)
NVDA   518.55 (-1.34%)
BABA   280.40 (+3.81%)
CGC   26.94 (+8.98%)
GE   10.45 (+3.77%)
MU   63.97 (-0.33%)
AMD   85.00 (-0.36%)
T   29.21 (+2.06%)
NIO   53.62 (-3.18%)
F   9.48 (+7.00%)
ACB   9.21 (+28.27%)
NFLX   482.90 (+1.32%)
GILD   60.25 (+0.60%)
BA   218.88 (+3.47%)
DIS   151.52 (+3.80%)
S&P 500   3,635.41 (+1.62%)
DOW   30,046.24 (+1.54%)
QQQ   294.64 (+1.46%)
AAPL   115.15 (+1.14%)
MSFT   213.65 (+1.68%)
FB   276.92 (+3.16%)
GOOGL   1,763.90 (+2.10%)
AMZN   3,120.51 (+0.71%)
TSLA   555.74 (+6.49%)
NVDA   518.55 (-1.34%)
BABA   280.40 (+3.81%)
CGC   26.94 (+8.98%)
GE   10.45 (+3.77%)
MU   63.97 (-0.33%)
AMD   85.00 (-0.36%)
T   29.21 (+2.06%)
NIO   53.62 (-3.18%)
F   9.48 (+7.00%)
ACB   9.21 (+28.27%)
NFLX   482.90 (+1.32%)
GILD   60.25 (+0.60%)
BA   218.88 (+3.47%)
DIS   151.52 (+3.80%)
Log in
NYSE:NVO

Novo Nordisk A/S SEC Filings & 10K Form

$66.00
-1.40 (-2.08 %)
(As of 11/24/2020 04:00 PM ET)
Add
Compare
Today's Range
$65.74
Now: $66.00
$66.34
50-Day Range
$63.89
MA: $69.07
$73.62
52-Week Range
$49.24
Now: $66.00
$73.81
Volume88,340 shs
Average Volume1.49 million shs
Market Capitalization$155.42 billion
P/E Ratio24.81
Dividend Yield1.09%
Beta0.43

SEC Filings

Novo Nordisk A/S (NYSE:NVO) SEC Filings

DateFilerForm TypeView
11/18/2020
5:05 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/17/2020
5:00 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/09/2020
7:17 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/09/2020
6:08 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2020
8:49 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2020
5:00 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2020
5:00 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2020
5:00 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2020
8:00 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2020
7:27 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/26/2020
9:38 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/19/2020
9:54 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/14/2020
6:48 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/08/2020
2:23 PM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/05/2020
8:53 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/28/2020
9:18 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/22/2020
5:00 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/14/2020
7:14 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/08/2020
5:05 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/31/2020
9:03 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/24/2020
9:24 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/17/2020
8:42 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/06/2020
11:21 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/06/2020
5:02 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/28/2020
6:46 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/20/2020
6:24 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/13/2020
6:29 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/06/2020
5:15 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/29/2020
9:52 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/29/2020
5:54 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/22/2020
8:03 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2020
10:00 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/15/2020
7:27 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/12/2020
8:51 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/05/2020
5:01 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2020
9:57 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2020
10:11 AM
Novo Nordisk A/S (Filer)
Form SD
Specialized Disclosure Report  
05/26/2020
5:10 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/13/2020
11:17 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/12/2020
9:43 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/12/2020
5:19 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/12/2020
5:16 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/12/2020
5:00 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/11/2020
12:50 PM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2020
6:16 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/05/2020
11:19 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2020
11:33 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2020
5:11 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2020
5:06 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/28/2020
5:00 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/20/2020
10:43 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/06/2020
11:30 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/06/2020
5:05 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/31/2020
9:25 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2020
5:01 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2020
10:19 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/23/2020
9:39 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/17/2020
8:06 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/17/2020
7:33 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/09/2020
9:21 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/03/2020
12:05 PM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2020
5:01 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/21/2020
5:10 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2020
5:14 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/11/2020
8:49 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/11/2020
8:46 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2020
11:16 AM
BlackRock Inc. (Filed by)
Novo Nordisk A/S (Subject)
Form SC 13G/A
02/05/2020
8:49 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2020
8:44 AM
Novo Nordisk A/S (Filer)
Form IRANNOTICE
02/05/2020
8:36 AM
Novo Nordisk A/S (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/05/2020
7:59 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/04/2020
7:37 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/03/2020
6:00 AM
Innate Pharma SA (Subject)
Novo Nordisk A/S (Filed by)
Form SC 13G
01/31/2020
10:29 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/27/2020
8:20 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/21/2020
5:30 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/17/2020
3:20 PM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/13/2020
10:04 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2019
10:54 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2019
8:08 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/18/2019
5:00 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/10/2019
7:08 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/03/2019
5:00 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/26/2019
5:05 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2019
7:01 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2019
9:16 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2019
9:05 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/12/2019
5:30 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2019
1:42 PM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2019
1:41 PM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2019
5:01 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2019
5:01 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/01/2019
7:06 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2019
9:39 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2019
9:51 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2019
8:25 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2019
5:37 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/07/2019
9:26 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/01/2019
5:05 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2019
9:44 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This page was last updated on 11/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.